Daniel Park
Profile
Daniel S.
Park served as the Executive Vice President at ILJIN Holdings Co., Ltd.
and as the Non-Executive Director & Chief Business Officer at Isotechnika Pharma, Inc. in 2012.
He also served as an Independent Director at Aurinia Pharmaceuticals, Inc. Mr. Park holds an MBA from the University of California, Los Angeles and completed his undergraduate and graduate studies at Seoul National University.
Former positions of Daniel Park
| Companies | Position | End |
|---|---|---|
Isotechnika Pharma, Inc.
 Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada. | Director/Board Member | 2012-06-27 |
| AURINIA PHARMACEUTICALS INC. | Director/Board Member | - |
| ILJIN HOLDINGS CO.,LTD. | Corporate Officer/Principal | - |
Training of Daniel Park
| University of California, Los Angeles | Masters Business Admin |
| Seoul National University | Graduate Degree |
Experiences
Positions held
Linked companies
| Listed companies | 2 |
|---|---|
| ILJIN HOLDINGS CO.,LTD. | Producer Manufacturing |
| AURINIA PHARMACEUTICALS INC. | Health Technology |
| Private companies | 1 |
|---|---|
Isotechnika Pharma, Inc.
Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada. | Health Technology |
- Stock Market
- Insiders
- Daniel Park
